Clinical Trial Update: BEBT-908 Plus Chemotherapy Treatment for CR MRD-Positive MEF2D-Rearranged and Pre-B Acute Lymphoblastic Leukemia Patients [Phase 2]

View source ↗

Summary

A Phase 2 clinical trial update notes BEBT-908 plus chemotherapy for CR MRD-positive MEF2D-rearranged and pre-B acute lymphoblastic leukemia patients, with the …

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Acute Lymphoblastic Leukemia
• Mef2d-rearranged Acute Lymphoblastic Leukemia
• Pre-b Acute Lymphoblastic Leukemia

Drugs mentioned

• BEBT-908 (BEBT-908)

Snippet

Sponsor: Ruijin Hospital | Conditions: Acute Lymphoblastic Leukemia | Phase 2 | Status: NOT_YET_RECRUITING